======= BCL10 ======= == Gene Information == * **Official Symbol**: BCL10 * **Official Name**: BCL10 immune signaling adaptor * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=8915|8915]] * **UniProt**: [[https://www.uniprot.org/uniprot/O95999|O95999]] * **Interactions**: [[https://thebiogrid.org/search.php?search=BCL10&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20BCL10|Open PubMed]] * **OMIM**: [[https://omim.org/entry/603517|Open OMIM]] == Function Summary == * **Entrez Summary**: This gene was identified by its translocation in a case of mucosa-associated lymphoid tissue (MALT) lymphoma. The protein encoded by this gene contains a caspase recruitment domain (CARD), and has been shown to induce apoptosis and to activate NF-kappaB. This protein is reported to interact with other CARD domain containing proteins including CARD9, 10, 11 and 14, which are thought to function as upstream regulators in NF-kappaB signaling. This protein is found to form a complex with MALT1, a protein encoded by another gene known to be translocated in MALT lymphoma. MALT1 and this protein are thought to synergize in the activation of NF-kappaB, and the deregulation of either of them may contribute to the same pathogenetic process that leads to the malignancy. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Mar 2016]. * **UniProt Summary**: Involved in adaptive immune response (PubMed:25365219). Promotes apoptosis, pro-caspase-9 maturation and activation of NF- kappa-B via NIK and IKK. May be an adapter protein between upstream TNFR1-TRADD-RIP complex and the downstream NIK-IKK-IKAP complex. Is a substrate for MALT1 (PubMed:18264101). {ECO:0000269|PubMed:18264101, ECO:0000269|PubMed:25365219}. |CARD| |interleukin-6 biosynthetic process| |lymphotoxin A production| |lymphotoxin A biosynthetic process| |positive regulation of mast cell cytokine production| |regulation of mature B cell apoptotic process| |CBM complex| |negative regulation of mature B cell apoptotic process| |regulation of mast cell cytokine production| |kinase activator activity| |B cell apoptotic process| |tumor necrosis factor superfamily cytokine production| |negative regulation of B cell apoptotic process| |interleukin-6 production| |protein kinase B binding| |positive regulation of interleukin-8 biosynthetic process| |cytokine biosynthetic process| |T cell apoptotic process| |cytokine metabolic process| |regulation of interleukin-8 biosynthetic process| |CARD domain binding| |regulation of B cell apoptotic process| |lymphocyte apoptotic process| |positive regulation of myeloid leukocyte cytokine production involved in immune response| |response to food| |leukocyte apoptotic process| |negative regulation of lymphocyte apoptotic process| |NF-kappaB binding| |lipopolysaccharide-mediated signaling pathway| |immunological synapse| |regulation of T cell receptor signaling pathway| |negative regulation of leukocyte apoptotic process| |positive regulation of interleukin-8 production| |response to fungus| |positive regulation of extrinsic apoptotic signaling pathway| |regulation of lymphocyte apoptotic process| |cytoplasmic microtubule| |cellular defense response| |positive regulation of cytokine production involved in immune response| |protein self-association| |regulation of antigen receptor-mediated signaling pathway| |positive regulation of cytokine biosynthetic process| |regulation of interleukin-8 production| |I-kappaB kinase/NF-kappaB signaling| |cellular response to mechanical stimulus| |regulation of leukocyte apoptotic process| |regulation of cytokine production involved in immune response| |neural tube closure| |tube closure| |kinase binding| |positive regulation of production of molecular mediator of immune response| |primary neural tube formation| |toll-like receptor signaling pathway| |protease binding| |regulation of cytokine biosynthetic process| |neural tube formation| |protein heterooligomerization| |stimulatory C-type lectin receptor signaling pathway| |positive regulation of protein ubiquitination| |innate immune response activating cell surface receptor signaling pathway| |embryonic epithelial tube formation| |pattern recognition receptor signaling pathway| |epithelial tube formation| |positive regulation of cysteine-type endopeptidase activity involved in apoptotic process| |positive regulation of protein modification by small protein conjugation or removal| |regulation of production of molecular mediator of immune response| |morphogenesis of embryonic epithelium| |tube formation| |cytokine production| |positive regulation of cysteine-type endopeptidase activity| |positive regulation of NF-kappaB transcription factor activity| |regulation of extrinsic apoptotic signaling pathway| |neural tube development| |positive regulation of endopeptidase activity| |Fc-epsilon receptor signaling pathway| |positive regulation of apoptotic signaling pathway| |T cell receptor signaling pathway| |positive regulation of I-kappaB kinase/NF-kappaB signaling| |cellular response to lipopolysaccharide| |protein C-terminus binding| |positive regulation of peptidase activity| |cellular response to molecule of bacterial origin| |regulation of protein ubiquitination| |positive regulation of T cell activation| |immunoglobulin mediated immune response| |B cell mediated immunity| |response to mechanical stimulus| |cellular response to biotic stimulus| |regulation of cysteine-type endopeptidase activity involved in apoptotic process| |positive regulation of leukocyte cell-cell adhesion| |positive regulation of immune effector process| |membrane raft| |regulation of protein modification by small protein conjugation or removal| |innate immune response-activating signal transduction| |regulation of I-kappaB kinase/NF-kappaB signaling| |Fc receptor signaling pathway| |regulation of cysteine-type endopeptidase activity| |lysosome| |positive regulation of cell-cell adhesion| |activation of innate immune response| |positive regulation of DNA-binding transcription factor activity| |lymphocyte mediated immunity| |adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains| |transcription coactivator activity| |ubiquitin protein ligase binding| |antigen receptor-mediated signaling pathway| |regulation of leukocyte cell-cell adhesion| |epithelial tube morphogenesis| |response to lipopolysaccharide| |cellular response to abiotic stimulus| |cellular response to environmental stimulus| |regulation of T cell activation| |response to molecule of bacterial origin| |transcription factor binding| |cellular response to external stimulus| |protein homooligomerization| |positive regulation of innate immune response| |enzyme binding| |positive regulation of proteolysis| |positive regulation of lymphocyte activation| |positive regulation of response to biotic stimulus| |regulation of cell-cell adhesion| |regulation of apoptotic signaling pathway| |positive regulation of leukocyte activation| |positive regulation of cell adhesion| |regulation of endopeptidase activity| |positive regulation of cell activation| |regulation of DNA-binding transcription factor activity| |morphogenesis of an epithelium| |negative regulation of immune system process| |regulation of peptidase activity| |immune response-activating cell surface receptor signaling pathway| |positive regulation of cytokine production| |regulation of innate immune response| |protein kinase binding| |regulation of immune effector process| |positive regulation of defense response| |immune response-regulating cell surface receptor signaling pathway| |response to nutrient levels| |positive regulation of multi-organism process| |regulation of lymphocyte activation| |protein complex oligomerization| |cellular response to lipid| |regulation of response to biotic stimulus| |response to extracellular stimulus| |immune response-activating signal transduction| |tissue morphogenesis| |embryonic morphogenesis| |positive regulation of kinase activity| |protein-containing complex| |immune response-regulating signaling pathway| |regulation of leukocyte activation| |positive regulation of response to external stimulus| |adaptive immune response| |activation of immune response| |chordate embryonic development| |regulation of cell activation| |positive regulation of apoptotic process| |positive regulation of programmed cell death| |embryo development ending in birth or egg hatching| |tube morphogenesis| |positive regulation of transferase activity| |regulation of cell adhesion| |protein ubiquitination| |response to bacterium| |regulation of cytokine production| |perinuclear region of cytoplasm| |positive regulation of cell death| |regulation of proteolysis| |regulation of defense response| |leukocyte mediated immunity| |innate immune response| |positive regulation of hydrolase activity| |protein modification by small protein conjugation| |regulation of multi-organism process| |tube development| |response to lipid| |positive regulation of immune response| |regulation of kinase activity| |negative regulation of apoptotic process| |anatomical structure formation involved in morphogenesis| |negative regulation of programmed cell death| |apoptotic process| |defense response to other organism| |embryo development| |regulation of transferase activity| |protein modification by small protein conjugation or removal| |negative regulation of cell death| |positive regulation of intracellular signal transduction| |programmed cell death| |cellular response to oxygen-containing compound| |positive regulation of phosphorylation| |identical protein binding| |cell death| |immune effector process| |regulation of response to external stimulus| |epithelium development| |positive regulation of phosphorus metabolic process| |positive regulation of phosphate metabolic process| |positive regulation of immune system process| |regulation of immune response| |response to abiotic stimulus| |positive regulation of protein modification process| |regulation of hydrolase activity| |response to other organism| |response to external biotic stimulus| |response to biotic stimulus| |defense response| |organonitrogen compound biosynthetic process| |positive regulation of catalytic activity| |regulation of response to stress| |positive regulation of transcription, DNA-templated| |regulation of apoptotic process| |response to oxygen-containing compound| |protein-containing complex assembly| |regulation of programmed cell death| |regulation of phosphorylation| |positive regulation of cellular protein metabolic process| |positive regulation of nucleic acid-templated transcription| |positive regulation of RNA biosynthetic process| |regulation of immune system process| |positive regulation of signal transduction| |regulation of cell death| |intracellular signal transduction| |positive regulation of protein metabolic process| |positive regulation of RNA metabolic process| |positive regulation of multicellular organismal process| |tissue development| |macromolecule biosynthetic process| |positive regulation of molecular function| |regulation of phosphate metabolic process| |regulation of phosphorus metabolic process| |positive regulation of cell communication| |positive regulation of signaling| |regulation of intracellular signal transduction| |regulation of protein modification process| |protein-containing complex subunit organization| |immune response| |positive regulation of nucleobase-containing compound metabolic process| |positive regulation of macromolecule biosynthetic process| |positive regulation of cellular biosynthetic process| |positive regulation of gene expression| |positive regulation of biosynthetic process| \\ === CRISPR Data === No hits were found. No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 11212 * **Expression level (log2 read counts)**: 3.81 {{:chemogenomics:nalm6 dist.png?nolink |}}